Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Response to Letter to the Editor Entitled “Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention”

Response to Letter to the Editor Entitled “Short and Long-Term Prognostic Significance of... Letter to the Editor Angiology 2023, Vol. 0(0) 1 © The Author(s) 2023 Response to Letter to the Editor Entitled Article reuse guidelines: sagepub.com/journals-permissions “Short and Long-Term Prognostic DOI: 10.1177/00033197231170435 journals.sagepub.com/home/ang Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention” 1 1 1 Ugur ˘ Koktürk, ¨ MD , Hamdi Püs¸üroglu, ˘ MD , Mustafa Umut Somuncu, MD , 1 2 1   Begüm Uygur, MD , Nilgün Is¸ıksaçan, MD , and AydınYıldırım, MD We thank Liu et al. for their interest in our paper entitled ORCID iDs “Short and Long-Term Prognostic Significance of Galectin-3 Ugur ˘ Koktürk ¨  https://orcid.org/0000-0003-0459-9295 in Patients with ST-Elevation Myocardial Infarction Un- Begum Uygur  https://orcid.org/0000-0003-3998-3713 dergoing Primary Percutaneous Coronary Intervention.” Nilgun Isiksacan  https://orcid.org/0000-0002-0230-6500 As we mentioned in our study, high galectin-3 levels are associated with heart failure (HF) development and rehospi- References talization in patients with ST-elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary 1. Liu H, Liu Y. Letter: galectin-3: an important but insufficiently intervention (pPCI). explored biomarker in cardiovascular disease. Angiology. 2023: Di Tano et al. found galectin-3 values to be significant in 331972311636. doi:10.1177/00033197231163699. ¨ ˘ predicting the combined primary outcome, including HF, in 2. Koktürk U, Püs¸üroglu H, Somuncu MU, et al. Short and long- 103 patients who underwent primary angioplasty for the first term prognostic significance of galectin-3 in patients with ST- time with anterior myocardial infarction. However, as stated elevation myocardial infarction undergoing primary percutaneous by Liu et al., the results supporting these findings have coronary intervention. Angiology. 2023: 331972211498. doi:10. generally been obtained from small-scale studies. 1177/00033197221149846. Our study had a small study population. Therefore, it may not 3. Di Tano G, Caretta G, De Maria R, et al. Galectin-3 and outcomes allow accurate association inference for a study investigating the after anterior-wall myocardial infarction treated by primary prognostic effect of a biomarker on cardiovascular events. More percutaneous coronary intervention. Biomark Med. 2018; 12: studies are needed for definitive findings to prove this. 21–26. Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Istanbul, Turkey Department of Biochemistry, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Istanbul, Turkey Corresponding Author: ˘ ¨ Ugur Koktürk, MD, Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, ˙ ¨ Istasyon Mah. Turgut Ozal Bulvar No: 11 Küçükçekmece, Istanbul 78050, Turkey. Email: drugurkokturk@gmail.com http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Angiology SAGE

Response to Letter to the Editor Entitled “Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention”

Loading next page...
 
/lp/sage/response-to-letter-to-the-editor-entitled-short-and-long-term-qFf6bThOGi

References (3)

Publisher
SAGE
Copyright
© The Author(s) 2023
ISSN
0003-3197
eISSN
1940-1574
DOI
10.1177/00033197231170435
Publisher site
See Article on Publisher Site

Abstract

Letter to the Editor Angiology 2023, Vol. 0(0) 1 © The Author(s) 2023 Response to Letter to the Editor Entitled Article reuse guidelines: sagepub.com/journals-permissions “Short and Long-Term Prognostic DOI: 10.1177/00033197231170435 journals.sagepub.com/home/ang Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention” 1 1 1 Ugur ˘ Koktürk, ¨ MD , Hamdi Püs¸üroglu, ˘ MD , Mustafa Umut Somuncu, MD , 1 2 1   Begüm Uygur, MD , Nilgün Is¸ıksaçan, MD , and AydınYıldırım, MD We thank Liu et al. for their interest in our paper entitled ORCID iDs “Short and Long-Term Prognostic Significance of Galectin-3 Ugur ˘ Koktürk ¨  https://orcid.org/0000-0003-0459-9295 in Patients with ST-Elevation Myocardial Infarction Un- Begum Uygur  https://orcid.org/0000-0003-3998-3713 dergoing Primary Percutaneous Coronary Intervention.” Nilgun Isiksacan  https://orcid.org/0000-0002-0230-6500 As we mentioned in our study, high galectin-3 levels are associated with heart failure (HF) development and rehospi- References talization in patients with ST-elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary 1. Liu H, Liu Y. Letter: galectin-3: an important but insufficiently intervention (pPCI). explored biomarker in cardiovascular disease. Angiology. 2023: Di Tano et al. found galectin-3 values to be significant in 331972311636. doi:10.1177/00033197231163699. ¨ ˘ predicting the combined primary outcome, including HF, in 2. Koktürk U, Püs¸üroglu H, Somuncu MU, et al. Short and long- 103 patients who underwent primary angioplasty for the first term prognostic significance of galectin-3 in patients with ST- time with anterior myocardial infarction. However, as stated elevation myocardial infarction undergoing primary percutaneous by Liu et al., the results supporting these findings have coronary intervention. Angiology. 2023: 331972211498. doi:10. generally been obtained from small-scale studies. 1177/00033197221149846. Our study had a small study population. Therefore, it may not 3. Di Tano G, Caretta G, De Maria R, et al. Galectin-3 and outcomes allow accurate association inference for a study investigating the after anterior-wall myocardial infarction treated by primary prognostic effect of a biomarker on cardiovascular events. More percutaneous coronary intervention. Biomark Med. 2018; 12: studies are needed for definitive findings to prove this. 21–26. Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Istanbul, Turkey Department of Biochemistry, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Istanbul, Turkey Corresponding Author: ˘ ¨ Ugur Koktürk, MD, Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, ˙ ¨ Istasyon Mah. Turgut Ozal Bulvar No: 11 Küçükçekmece, Istanbul 78050, Turkey. Email: drugurkokturk@gmail.com

Journal

AngiologySAGE

Published: Oct 1, 2023

There are no references for this article.